Second generation of targeted drugs.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D000922:Immunotoxins / Q000276:immunology* / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000922:Immunotoxins